A family legacy in pharmaceuticals, driven by the belief that healthcare should add smiles to life.
Stelios Pharmaceuticals LLP was established on May 10, 2012, by co-founders Mr. Venkateswaran Kailasam Kalpathy and Mrs. Vasanthi Venkateswaran. The roots of Stelios trace back to 1958, when Mr. Venkateswaran's father, the late K.V. Kailasam, joined a prominent pharmaceutical company to gain industry insight.
Inspired early in life, Mr. Venkateswaran began his career in the sector on July 13, 1987. Across a 37-year journey he has worked with many esteemed pharmaceutical companies, consistently bringing the same enthusiasm and energy he carries today.
At Stelios, every step we take is aimed at enhancing lives and fostering wellness. We are committed to healthcare excellence through our WAA principle — World-Class Products, Affordability and Accessibility. Stelios is synonymous with "Adding Smiles to Life."
Quality is non-negotiable. Our products are manufactured under WHO-GMP and ISO 9001:2015 standards and independently tested at India's leading laboratories, so every formulation that carries the Stelios name is verified to be top-notch.
We hold our parents in the deepest respect; they nurtured us with truthfulness and a strong value system we continue to uphold. Guided especially by the belief in excellent healthcare championed by Mrs. Parvathy Kailasam, Stelios is dedicated to enhancing lives while upholding the highest ethical standards.
Our ambition for 2030 is bold and clear: to establish Stelios as a globally respected name in pharmaceuticals — extending our reach beyond India's borders while keeping world-class healthcare affordable and accessible to all.
Awarded for outstanding contribution to quality and excellence, customer satisfaction, and impact on society — a milestone that strengthens our mission to keep raising the bar.
